Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Cellular Biochemistry|January 5, 2007
The immunosuppressant FTY720 inhibits tumor angiogenesis via the sphingosine 1-phosphate receptor 1Gerald Schmid, Markus Guba, Ivan Ischenko, et al.
American Journal of Surgery|April 13, 2010
Risk factors for surgical complications in distal pancreatectomyHendrik Seeliger, Simone Christians, Martin K Angele, et al.
Molecular Cancer Research : MCR|February 12, 2009
EFEMP1 expression promotes in vivo tumor growth in human pancreatic adenocarcinomaHendrik Seeliger, Peter Camaj, Ivan Ischenko, et al.
Blood|January 27, 2005
Rapamycin induces tumor-specific thrombosis via tissue factor in the presence of VEGFMarkus Guba, Maksim Yezhelyev, Martin E Eichhorn, et al.
International Journal of Cancer|August 22, 2009
Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancerMartin E Eichhorn, Ivan Ischenko, Siiri Luedemann, et al.
Anti-Cancer Drugs|April 7, 2007
Antiangiogenic and antitumor activity of a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor ZD6474 in a metastatic human pancreatic tumor modelClaudius Conrad, Ivan Ischenko, Gudrun Köhl, et al.
Targeted Oncology|June 22, 2014
Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasisHanno Niess, Peter Camaj, Andrea Renner, et al.
Targeted Oncology|February 3, 2015
Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancerYue Zhao, Lu Zhao, Ivan Ischenko, et al.
Pageof 2